chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Site injection sensitivity that is lingering; This is a spontaneous report received from a contactable reporter, Consumer. The reporter is the patient. A 57-year-old female patient (not pregnant) received (PFIZER-BIONTECH COVID-19 VACCINE), administered in arm left, administration date 03Mar2021 09:00 (Batch/Lot number: unknown) at the age of 57 years as dose 1, single for covid-19 immunisation. Relevant medical history included: "rt hip replacement", start date: Aug2019 (unspecified if ongoing), notes: right; "bilateral frozen shoulders" (unspecified if ongoing), notes: bilateral frozen shoulders that had resolved; "bilateral frozen shoulders", start date: Aug2019 (unspecified if ongoing), notes: came back in Aug2019. Concomitant medications included: NAPROXEN and daily vitamin. The following information was reported: VACCINATION SITE HYPERAESTHESIA (non-serious) with onset 03Mar2021, outcome "not recovered", described as "Site injection sensitivity that is lingering". Therapeutic measures were not taken as a result of vaccination site hyperaesthesia. Additional information: The patient had no known allergies. The patient did not have Covid prior to vaccination and was not tested for Covid post vaccination.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.; Sender's Comments: Linked Report(s) : US-PFIZER INC-2021373325 same patient, same drug, different, different dose of vaccine
Pt became very fussy approx 8 hrs p/inject & had a fever of 104; grandparents gave PAPA every 4 hrs & had to sponge bathe pt to bring temp down; pt was very irritable, crying all noc; rt thigh was swollen, hard, inflamed x 36 hrs;
tickling in throat, dry cough, clear nasal, discharge, normal temps tri-care nurse advised using Dm tussin cough med;little phlegm coughed up & head congestion upon arising in Am;
30 minutes post vaccine administration the patient became hypotensive, diaphoretic, and had shallow respirations. Patient was on dialysis treatment at the time and was rinsed back with 500 ml NS, placed on 2L O2 via NC, and given 1 dose of epi IM. Patient responded well to interventions and was alert and oriented prior to arrival of EMS. EMS arrived to evaluate the patient. Patient's daughter arrived to take patient to ER to be evaluated.
r/o cellulitis rt deltoid;3cm red & swollen & tender;Keflex x 10 days ice & APAP
Drug store is doing covid vaccine clinics for long term care facilities, It was noted that the patient received a 3rd dose of covid vaccine (pfizer) on 2/19/21. facility confirmed and no adverse events reported
The site of the injection itches (or tingles or slightly hurts). It also appears red, but just right at the site.
Patient received COVID 19 Johnson & Johnson on 4/8/2021. developed cough that evening. Following day 4/9/2021 developed headache, fever, chills, body aches. Self resolved 4/10/2021. Had clinic visit 4/20/2021 with persistent dry cough denies any other symptoms, not self medicated. RX. Ibuprofen, Pro Air Inhaler, Tessalon Perles.
Rash on back; Severe lower Back pain; dose received: 3; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP).  A 75 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), intramuscular, administered in arm left, administration date 17Dec2021 (Batch/Lot number: unknown) at the age of 75 years as dose 3 (booster), single for covid-19 immunisation. Relevant medical history included: "allergies Sulpha" (unspecified if ongoing), notes: Known allergies: Sulpha. The patient took concomitant medications. Vaccination history included: Bnt162b2 (Dose Number: 2 Batch/lot number unknown), for COVID-19 Immunization; Bnt162b2 (Dose Number: 1 Batch/lot number unknown), for COVID-19 Immunization. The following information was reported: IMMUNISATION (non-serious) with onset 17Dec2021, outcome "unknown", described as "dose received: 3"; RASH (non-serious) with onset 22Dec2021 09:00, outcome "not recovered", described as "Rash on back"; BACK PAIN (non-serious) with onset 22Dec2021 09:00, outcome "not recovered", described as "Severe lower Back pain". The events "rash on back" and "severe lower back pain" were evaluated at the physician office visit. Relevant laboratory tests and procedures are available in the appropriate section. Therapeutic measures were taken as a result of rash, back pain.  Additional Information: The patient did not received any other vaccines within 4 weeks prior to the COVID vaccine. List of any other medications the patient received within 2 weeks of vaccination was Yes unknown. The Patient received treatment for the adverse event with Pain medication and antibiotic. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had been tested for COVID-19.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
2nd dose in Moderna series. 1st dose administered on 5/5/2021 inadvertently. Pt's legal guardian and patient were informed that 2nd dose would be considered off-label use for under-age patient. Consent provided for 2nd dose to be administered as per vaccination schedule.
flare up of hashimotos hypothyroid; Significant and rapid hair loss; including skin and hair issues; including skin and hair issues; Booster; This is a spontaneous report received from a non-contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 43-year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administered in arm left, administration date 02Dec2021 16:45 (Batch/Lot number: unknown) at the age of 43 years as dose 3 (booster), single for covid-19 immunisation. Relevant medical history included: "Hashimoto's Thyroid" (unspecified if ongoing); "Known allergy: Penicillin" (unspecified if ongoing). Concomitant medication(s) included: LEVOTHYROXINE; AMBIEN; VITAMIN D [VITAMIN D NOS]. Vaccination history included: Bnt162b2 (dose 2, lot number: ER8737, administration time: 04:00 PM , vaccine location: left arm), administration date: 29Mar2021, when the patient was 43 years old, for Covid-19 immunization, reaction(s): "chills", "fever/low grade fever", "head/body ache", "fatigue", "swelling/redness and pain at injection site", "disrupted menstrual cycle", "heavy/longer than usual menstrual period", "flare up of hashimotos hypothyroid", "skin and hair issues at this time", "hair loss"; Pertussis vaccine, reaction(s): "Known allergies: pertussis vaccine". These occurred after second dose and lasted 6 months. Her hair was starting to regrow and then after booster began to fall out again. She experienced significant and rapid hair loss. Never had hair loss prior, it was sudden significant, and resulted in a thinning across the scalp particularly in the top of head and temple area. Estimate1/4 reduction of volume in this area. Have also experienced flare up of hashimotos hypothyroid including skin and hair issues at this time. Had been stable with medication for more than 5 years prior. The events "booster", "flare up of hashimotos hypothyroid", "significant and rapid hair loss", "including skin and hair issues" and "including skin and hair issues" were evaluated at the physician office visit. Therapeutic measures taken as a result of events included adjustment of thyroid medication. The patient had not recovered from flare up of hashimotos hypothyroid, significant and rapid hair loss, skin and hair issues. No covid prior to vaccination and was not tested post vaccination.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
severe pain in right arm starting 2 days after injection, lasting through today, arm is weakening flu like symptoms starting 1 week after first injection through 4/13/21 right arm is now burning and hurting deep in shoulder area lower back is hurting in kidney area, pain and pressure like swelling
Information has been received from a nurse referring to an unspecified number of patients of unknown age and gender. Within the past months (from 13-MAY-2015 to 13-JUL-2015), the patients were vaccinated with improperly stored doses of GARDASIL (lot # K007828, expiration date 02-MAR-2017; lot # 23432, expiration date 18-JUN-2016, 0.5 ml, intramuscularly). No adverse effects were reported. This is one to two reports received from the same source. Additional information has been requested.
pt saw MD, rx APAP, soon recovered from leg red & swollen, t102, crying hard for 1/2hr, intermittent crying all afternoon;
Developed symptoms within 10min of vaccine shot. Feeling hot and nauseous, sensation of feeling ?off?, rapid heartbeat, shaky hands. Similar to onset of more severe allergies in the past. Medical team have emergency juice and crackers and we stayed at site about 40minutes. I had some lower stomach cramps and waves of feeling strange  and a bit confused and chills. It didn?t get worse but I still felt  nausea and just strange, so we drove home.  ( husband drove, I could not drive). About 30min into the drive we had to stop and go to a park toilet because I had sudden painful stomach cramps and the I had  diarrhea (severe). Started feeling less strange and more clear headed after that. At home I took one Benadryl  and Zyrtec, had more diarrhea but not severe, a bit nauseous,  and felt better after 2-3 hours. No more issues after that, just a sore arm.
Right arm was throbbing, so I looked at it and noticed it was breaking out into a petechiae rash from just below the injection site down to my hand.
Initial pain and redness, 3 in circle.  Itiching to site on day 3. 3 inch cirle looked bruised on day 11.  Day 13 another 2-3 inches around initial bruised sitr now red and swollen. Pain improved by day 3.
12/11/2022- Presents to ED, worsening SOB and cough. Afebrile. 02 mid 90's on 6L NCL (4L and cpap at HS baseline). Covid + test. CXR-b/l infiltrates . ABG 7.47/38/63/27 6L 02 via NC. Dexamethasone, hold remdesivir d/t elevated LFT's-AST 63 and ALT 66, transaminases 60's trending down. IV vanco and cefepime. Admit Acute on chronic hypoxemic respiratory failure b/l covid pna causing copd exacerbation. eGFR 27. WBC 15.8. AKI creat 2.4. BUN 87 . recently d/c 12/9 after 5 weeks stay COPD exacerbation and CAP.  12/12/-2022- cefepime d/c start meropenem. Pseudomonas.  12/19/2022-On 8L o2 via NC sat above 90's. IV decadron and meropenem. procalcitonin 0.10 and crp 1.3 d/c vanco.  12/27/2022- Transaminitis resolving, WBC 1
Vaccine administered after 9 days of puncturing the vial; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Vaccine administered after 9 days of puncturing the vial) in a 64-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 006C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 03-Sep-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 03-Sep-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Vaccine administered after 9 days of puncturing the vial). On 03-Sep-2021, EXPIRED PRODUCT ADMINISTERED (Vaccine administered after 9 days of puncturing the vial) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medication was reported by reporter. No treatment medication was reported by reporter.   Most recent FOLLOW-UP information incorporated above includes: On 28-Sep-2021: Follow up received contains updated event verbatim
The pfizer vaccine was not diluted prior to administration. 0.2ml of the undiluted vaccine was administered in the left deltoid at 9:12am. This was caught by a coworker in less than an hour and reported to the lead provider. The patient, pfizer manufacturing and poison control were all contacted promptly.
Diagnosed with cervical radiculopathy; Receiving the Pfizer booster; This is a spontaneous report from a contactable consumer. This consumer (patient) reported for herself that a 61-year-old non-pregnant female patient received booster dose of bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Solution for injection; Lot Number: FF2587), via an unspecified route of administration, administered in left arm as dose 3 (booster), single on 23Oct2021 12:00 (at the age of 61-year-old) for covid-19 immunization at pharmacy or drug store. Medical history included type 1 diabetes mellitus from an unknown date and unknown if ongoing. Patient had no known allergies. Concomitant medications included atorvastatin calcium, insulin lispro (HUMALOG), lisinopril, ergocalciferol (VIT D [ERGOCALCIFEROL]), and vitamin b complex (B COMPLEX [VITAMIN B COMPLEX]) all taken for an unspecified indication, start and stop date were not reported. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine and received no other medications within 2 weeks of vaccination Humalog, Lisinopril, Atorvastatin, Vita D, B complex. Patient had not been diagnosed with COVID-19 prior to vaccination and had not been tested since the vaccination. Historical vaccine included patient previously took first and second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Solution for injection; Lot Number: Unknown), via an unspecified route of administration, as dose 1, single and dose 2, single on unspecified date for covid-19 immunization. Four days after receiving the Pfizer booster, patient woke up with severe pain in neck, left upper shoulder, radiating down the left arm with left arm weakness and tingling fingers on 27Oct2021 12:00 AM. Pain intensified over the next week so finally went to urgent care. On 03Nov2021, patient was diagnosed with cervical radiculopathy and never had any issues with pinched nerves prior to this time. Adverse event resulted in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were taken as a result of adverse events with pain meds and muscle relaxants. At the time of this report, the outcome of event was not recovered.    Follow-up attempts are completed. No further information is expected.
The whole school had the Moderna vaccine and were out for four days; This spontaneous case was reported by a nurse and describes the occurrence of IMMUNISATION REACTION (The whole school had the Moderna vaccine and were out for four days) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 prophylaxis.   No Medical History information was reported.  On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced IMMUNISATION REACTION (The whole school had the Moderna vaccine and were out for four days). At the time of the report, IMMUNISATION REACTION (The whole school had the Moderna vaccine and were out for four days) outcome was unknown.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.  For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.  No concomitant medication information was reported. No treatment medication information was reported.  This case was identified as part of a retrospective clean-up activity where certain emails received in the Moderna mailbox were missed to be booked-in.   This case was linked to US-MODERNATX, INC.-MOD-2021-624107 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-624107:Same reporter (Daughter case)
Ongoing low grade fever (as high as 100.6) and fatigue for 13 days so far after 2nd COVID-19 vaccination.
Chest pain, left location, constant at first and progressing to intermittent over the course of 3 months, not associated with food, position or exertion. Fever, resolved within days.
A report has been received from a Pharmacist concerning a 40 year old, Female subject, who had been receiving FLUMIST quadrivalent (intranasal). FLUMIST quadrivalent (intranasal) started on an unknown date. The reporter stated that patient experienced expired FLUMIST quadrivalent administered which started on 23-Dec-2014. The outcome of the event of expired FLUMIST quadrivalent administered is unknown. The report was considered to be non-serious.
This spontaneous report as received from a other health professional refers to a 4 year old male patient with prophylaxis. On 02-AUG-2017 the patient was vaccinated with ZOSTAVAX lot # M038863 for prophylaxis. Other suspect therapies included VARIVAX and sterile diluent (MRK). On 02-AUG-2017, 1 day after onset of therapy the patient experienced wrong drug administered. On an unknown date the patient experienced no adverse event. Lot number N015478 has been verified to be a valid lot number for sterile diluent (MRK). Additional information has been requested.
Rash over torso, Extreme fatigue, headache, neck ache, extreme pain in all muscles in joints all over body, nausea, vomiting, loss of appetite
One week after having Pfizer Booster dose #3 on 10-8-2021, administered in Right hip IM by my request I developed small patch of vesicular sensitive lesions on right flank consistent appearance and location of Shingles/zoster. At age 49 somewhat unusual/young.  Visual diagnosis as commonly done confirmatory immediately upon arising on 10-15-2021 by myself as practicing NP and colleague physician/internist  on site with me when rash identified. Next day more classic vesicular features seen - photos taken.  Saturday though so no culture done and not deemed necessary. Minimal pain, immediately started Antiviral therapy highly effective- contained the rash without escalation of lesions or symptoms. Today is one week out and seems contained/resolving.
7/28/2010 c/o pain in arm after last injection on 7/23/2010.  Also, c/o discomfort in neck. 7/29/2010 c/o discomfort in cervical spine to her bra line (back). Voiced not sure if it was the vaccine or her sixty hour week.  Denied redness, swelling, fever, rash at the injection site. " Don't worry I am O.K."
pt recvd vax 18MAY93 & 20MAY pt had hives 5-6" in diameter @ inject site; warm compresses & APAP prescribed; 21MAY pain & discomfort reported;
Besides regular side effects, I developed tinnitus in both ears, it's been a week after the vaccine and it's not getting better. My husband had a mild tinnitus in his right ear and now tinnitus became unbearable. We both had moderna.
pt states felt pain immed @ time of inj;reports pain as unbearable, throbbing, shooting pain from lt ax to ring finger;waited for few mins p/inj & returned to work reported discomfort to supervisor who called rescue squad;taken to ER given;
Patient had a bloody nose used proper procedures to stop the bleeding and took vitals those appeared normal for this patient.
No adverse reaction Reported. In November 2022 our State Immunization VFC program did our every-other-year audits in both our offices. It was discovered at that time, that some Covid vaccines were administered outside of the 10 week expiration date (which is calculated from the date the vaccines were received from the State.)
Acute-onset weakness, pins and needles, tingling, nerve blankets, limb nausea in full body.  Worsened from June to October 2021, symptoms improved a little from October to present.  At present, full body paresthesia, worst in feet and legs.  No treatment to date as potential diagnosis discovered a week ago.  Outcome to date: post exertional malaise and feet condition means I cannot be as active as before onset.
Hep A and Menactra vaccines given to left deltoid on 6/11/08 and Tdap given to right deltoid on 6/11/08. Developed fever that day. Then on 6/13/08 developed pain, redness, and swelling at injection sites bilaterally, left greater than right.
Patient received all three vaccinations and seemed fine.  She walked out of the immunization room and felt lightheaded and fell and hit her head.  She never lost consciousness.  After talking with the patient she said she often feels lightheaded and dizzy after getting vaccines, but after a few minutes usually feels better.  We continued to monitor her and she felt better.
On 12/25, I woke up feeling fatigued with slight body aches. I had significant soreness in my left arm where I received the vaccine, radiating down to my forearm. At approximately 7-8pm, I felt extremely cold.  I then noticed I had a flat, red rash on my face, chest, upper back, and shoulders.  There was no difficulty breathing, swallowing, or associated itching. My temperature was 99.0.  I went to bed at approximately 10pm, with no change in the rash.  I woke up the next morning at about 6am.  The rash was gone, and I felt well.  On 12/31, I developed moderate itching in the area of my left upper arm.  I noticed swelling, redness, and warmth in what felt like the exact area where I received my injection.  This continued into 1/1 except the itching had resolved, and I felt point tenderness as well as a cool, tingling sensation in my left upper arm. On 1/2 there was a shadow of redness in the area of my left upper arm, but the warmth, swelling, and tingling sensation had resolved.
Persistent inconsolable crying, last 10 hours the day of 1st vaccine on 11/6/02. Inconsolable crying after 2nd vaccine.